US Dry Eye Syndrome Market

ID: MRFR/Pharma/14229-HCR
100 Pages
Vikita Thakur
Last Updated: April 24, 2026
US Dry Eye Syndrome Market Research Report: Size, Share, Trend Analysis By Product Type (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Surgical Devices), By Cause of Dry Eye Syndrome (Aging, Medication Induced, Environmental Factors, Medical Conditions), By Distribution Channel (Online Pharmacy, Retail Pharmacy, Hospital Pharmacy, Specialty Clinics) and By End Users (Hospitals, Ophthalmology Clinics, Home Care) - Growth Outlook & Industry Forecast 2025 To 2035
US Dry Eye Syndrome Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.33%
2024 Market Size$ 1,085.7 Million
2025 Market Size$ 1,143.57 Million
2035 Market Size$ 1,922.55 Million
Key Players
Allergan
Santen Pharmaceutical
Novartis
Bausch Health
Otsuka Pharmaceutical
Hyaluronic Acid
Trends
  • Rising Awareness and Diagnosis
  • Technological Advancements in Treatment
  • Shift Towards Personalized Care
Opportunities
  • Impact of Environmental Factors
  • Advancements in Pharmaceutical Solutions
  • Growing Focus on Eye Health and Wellness
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Type (USD Million)
      1. 4.1.1 Artificial Tears
      2. 4.1.2 Anti-Inflammatory Drugs
      3. 4.1.3 Punctal Plugs
      4. 4.1.4 Surgical Devices
    2. 4.2 Construction, BY Cause of Dry Eye Syndrome (USD Million)
      1. 4.2.1 Aging
      2. 4.2.2 Medication Induced
      3. 4.2.3 Environmental Factors
      4. 4.2.4 Medical Conditions
    3. 4.3 Construction, BY Distribution Channel (USD Million)
      1. 4.3.1 Online Pharmacy
      2. 4.3.2 Retail Pharmacy
      3. 4.3.3 Hospital Pharmacy
      4. 4.3.4 Specialty Clinics
    4. 4.4 Construction, BY End User (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Ophthalmology Clinics
      3. 4.4.3 Home Care
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Allergan (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Santen Pharmaceutical (JP)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Novartis (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Bausch Health (CA)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Otsuka Pharmaceutical (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Hyaluronic Acid (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Johnson & Johnson (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Eyevance Pharmaceuticals (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY CAUSE OF DRY EYE SYNDROME
    4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    5. 6.5 US MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY CAUSE OF DRY EYE SYNDROME, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY CAUSE OF DRY EYE SYNDROME, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY END USER, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY CAUSE OF DRY EYE SYNDROME, 2025-2035 (USD Million)
      3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Dry Eye Syndrome Market Segmentation

US Dry Eye Syndrome Market By Type (USD Million, 2025-2035)

  • Artificial Tears
  • Anti-Inflammatory Drugs
  • Punctal Plugs
  • Surgical Devices

US Dry Eye Syndrome Market By Cause of Dry Eye Syndrome (USD Million, 2025-2035)

  • Aging
  • Medication Induced
  • Environmental Factors
  • Medical Conditions

US Dry Eye Syndrome Market By Distribution Channel (USD Million, 2025-2035)

  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Clinics

US Dry Eye Syndrome Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Ophthalmology Clinics
  • Home Care

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.